The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma

Early Stage Hepatocellular Carcinoma Clinical Trial

Official title: A Randomized, Controlled Trial of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma

Status Recruiting

Clinical Trial Summary

This study will assess the clinical efficacy and safety of fluorouracil implants regional chemotherapy during the surgical treatment for early-stage hepatocellular carcinoma.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Carcinoma
• Carcinoma, Hepatocellular
• Early Stage Hepatocellular Carcinoma

• NCT number: NCT01055743
• Study type: Interventional
• Source: Simcere Pharmaceutical Co., Ltd
• Contact: Shuqun Cheng, MD
• Phone: 86-021-81875251
• Status: Recruiting
• Phase: Phase 2
• Start date: August 2009
• Completion date: August 2014